Chemed Stock Profit Margin
| CXM Stock | EUR 545.00 5.00 0.91% |
Chemed fundamentals help investors to digest information that contributes to Chemed's financial success or failures. It also enables traders to predict the movement of Chemed Stock. The fundamental analysis module provides a way to measure Chemed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chemed stock.
Chemed |
Chemed Company Profit Margin Analysis
Chemed's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Chemed Profit Margin | 0.12 % |
Most of Chemed's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chemed is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Chemed has a Profit Margin of 0.1169%. This is 101.04% lower than that of the Healthcare sector and 102.28% lower than that of the Medical Care industry. The profit margin for all Germany stocks is 109.2% lower than that of the firm.
Chemed Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chemed's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chemed could also be used in its relative valuation, which is a method of valuing Chemed by comparing valuation metrics of similar companies.Chemed is currently under evaluation in profit margin category among its peers.
Chemed Fundamentals
| Return On Equity | 0.35 | |||
| Return On Asset | 0.16 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 7.54 B | |||
| Shares Outstanding | 14.95 M | |||
| Shares Owned By Insiders | 2.88 % | |||
| Shares Owned By Institutions | 95.31 % | |||
| Price To Earning | 32.25 X | |||
| Price To Book | 10.47 X | |||
| Price To Sales | 3.39 X | |||
| Revenue | 2.13 B | |||
| Gross Profit | 765.09 M | |||
| EBITDA | 393.44 M | |||
| Net Income | 249.62 M | |||
| Cash And Equivalents | 3.32 M | |||
| Cash Per Share | 0.21 X | |||
| Total Debt | 92.5 M | |||
| Debt To Equity | 30.10 % | |||
| Current Ratio | 0.81 X | |||
| Book Value Per Share | 53.70 X | |||
| Cash Flow From Operations | 309.89 M | |||
| Earnings Per Share | 15.57 X | |||
| Price To Earnings To Growth | 2.52 X | |||
| Target Price | 577.25 | |||
| Number Of Employees | 14.17 K | |||
| Beta | 0.52 | |||
| Market Capitalization | 7.23 B | |||
| Total Asset | 1.44 B | |||
| Z Score | 47.8 | |||
| Annual Yield | 0 % | |||
| Five Year Return | 0.42 % | |||
| Net Asset | 1.44 B | |||
| Last Dividend Paid | 1.48 |
About Chemed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chemed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chemed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chemed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Chemed Stock
Chemed financial ratios help investors to determine whether Chemed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chemed with respect to the benefits of owning Chemed security.